Harnessing digital PCR for rapid sterility testing
Join this webinar to explore rapid sterility testing methods that ensure fast, reliable product release, addressing critical challenges in timely delivery and safety.
This webinar focuses on rapid sterility testing solutions essential for products with short shelf lives. Learn how advanced digital PCR technology can ensure timely and safe product release.
Traditional sterility testing methods take up to 14 days, which is impractical for products like cell-based therapeutics with limited shelf life. Rapid sterility testing is crucial to meet the demands of timely delivery without compromising safety.
This session will explore the necessity and impact of rapid testing in the pharmaceutical industry and tackle the challenge of long testing times that delay product release, affecting delivery schedules and potentially compromising patient safety.
Speakers will discuss key innovations in digital PCR technology, providing actionable insights into improving testing efficiency and accuracy.
The session will discuss future trends in sterility testing and showcase successful rapid sterility testing in cell and gene therapy products, demonstrating practical applications and benefits.
Key learning points:
- Discover rapid sterility testing methods that address the challenge of lengthy testing times, improving efficiency and ensuring timely product release
- Gain insights into how digital PCR technology enhances testing accuracy and sensitivity, detecting contaminants quickly and reliably
- Understand the evolving landscape of sterility testing in the pharmaceutical industry, identifying both challenges and opportunities for growth
- Learn from real-world case studies on rapid testing implementations in the field of cell and gene therapy
- Explore strategies to maintain product safety and quality while meeting tight delivery schedules, enhancing overall operational effectiveness.
A Q&A session at the end of the webinar gives the audience a chance to ask questions, such as how to implement these technologies effectively.
Register to secure your spot today >>>
SPEAKERS
Dr Robert Hertel – Senior Scientist, Sartorius
Dr Hertel is a Senior Scientist focusing on PCR based product and application development to asses critical quality attributes of ATMP products.
Dr Edoardo Prediletto – Analytical Development Research Scientist, Autolus
Edoardo Prediletto, MSc PhD, is a Research Scientist in Analytical Development at Autolus Therapeutics, supporting the development and implementation of molecular methods for quality control and sterility testing in ATMPs. He is an Immunologist with extensive experience in PCR and digital PCR–based assays, including method development and optimisation within regulated industrial environments.
FAQs
FAQs
Is the panel discussion free?
Yes – there is no charge to watch the panel discussion, either live or on-demand.
When will the panel discussion take place?
18 March 2026 at 3PM GMT.
Can I watch it later?
The panel discussion will become available to watch on-demand shortly after the live webinar takes place.
What are the benefits of attending live?
You’ll be able to ask the speakers your questions, which will be answered live in the Q&A towards the end of the session.
How long will the panel discussion be?
This panel discussion will last up to an hour.
What do I need to watch this panel discussion?
All you need is a computer with an internet connection. We recommend using headphones if possible if you’re in an office environment.
